Newsroom
Category
November 4, 2015
After breast cancer surgery, women are prescribed adjuvant (or follow-up) therapies such as chemotherapy to reduce the risk of the cancer returning. It’s been assumed that the treatment effects of these therapies remain constant over time, but a new study from the CTRC suggests the opposite is true.
November 2, 2015
After breast cancer surgery, women are prescribed adjuvant (or follow-up) therapies such as chemotherapy and endocrine drugs to reduce the risk of the cancer returning. It’s been assumed that the treatment effects of these therapies remain constant over time, but a new study from the Cancer Therapy & Research Center (CTRC) at The University of Texas Health Science Center at San Antonio suggests the opposite is true.
November 2, 2015
Young patients and survivors age 14 and up, along with their parents and siblings, are invited to the Childhood Cancer & Blood Disorders College and Career Fair this weekend.
October 20, 2015
The 23nd Annual San Antonio Express-News Book & Author Luncheon benefits the Cancer Therapy & Research Center at The University of Texas Health Science Center at San Antonio.
October 16, 2015
Research projects focus on improving treatment benefit while sparing normal tissues; CTRC volunteer to be honored.
October 2, 2015
An experimental gene therapy essentially doubled the overall survival of patients with recurrent glioblastoma compared to the current standard of care, according to a study by the Cancer Therapy & Research Center (CTRC) at The University of Texas Health Science Center at San Antonio.